Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 

This article is part of the supplement: Symposium Mammographicum 2006

Oral Presentation

How are symptomatic services run in the United Kingdom?

I Monypenny

Cardiff & Vale NHS Trust and Breast Test Wales, Cardiff, UK

corresponding author email

from Symposium Mammographicum 2006
Bournemouth, UK. 9–11 July 2006

Breast Cancer Research 2006, 8(Suppl 1):P5doi:10.1186/bcr1420

Published: 10 July 2006

Oral Presentation

Breast clinics have developed in a fairly ad hoc way over the past 15 years, often led by experience from breast screening clinics. Although the concept of multidisciplinary teams is now well established, the interaction between members of the teams is much less well defined, particularly as to who is responsible for managing patients through the diagnostic pathway.

As part of the Association of Breast Surgery at BASO symptomatic audits that have been carried out over the past 6 years, some units have submitted data on all patients seen in their clinics, giving a dataset of over 100,000 patients from 58 breast units (median age 45, range 1–102). Overall 53% of patients have ultrasound and 57% mammography, with both imaging methods used in 32%. Needle biopsies (core or fine needle aspiration cytology) are carried out on 26% of patients, with 69% showing benign pathology. The pre-operative cancer diagnosis rate is 91%.

This dataset has been explored to look at variation in practice across units, and shows quite wide variation in the reported use of mammo-graphy (26–100%), ultrasound (4–96%), and needle biopsy (6–57%), although this does not obviously alter the cancer diagnosis rates for individual units. These results will be presented to inform discussion on what may be best practice.

Have something to say? Post a comment on this article!


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions